Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 15, 2017
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
Thu, September 14, 2017
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
Christopher Raymond Initiated (BMRN) at Buy on, Sep 14th, 2017
Christopher Raymond of Piper Sandler, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy on, Sep 14th, 2017.
Christopher has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $89 on, Thursday, July 27th, 2017
This is the rating of the analyst that currently disagrees with Christopher
- Josh Schimmer of "Evercore ISI Group" Initiated at Buy on, Thursday, August 17th, 2017
Similar Stocks and Investing Articles
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Aug 17th 2017
] - WOPRAI
[ Thu, Aug 17th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI
[ Wed, May 17th 2017
] - WOPRAI
[ Thu, Aug 04th 2016
] - WOPRAI
[ Tue, Nov 10th 2015
] - WOPRAI
[ Mon, Feb 25th 2013
] - WOPRAI
[ Thu, Sep 27th 2012
] - WOPRAI